Young MR - Search Results

1

Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma.

Walsh JE, Lathers DM, Chi AC, Gillespie MB, Day TA, Young MR. Walsh JE, et al. Among authors: young mr. Curr Treat Options Oncol. 2007 Jun;8(3):227-38. doi: 10.1007/s11864-007-0032-2. Curr Treat Options Oncol. 2007. PMID: 17712533 Review.

2

Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma.

Young MR, Neville BW, Chi AC, Lathers DM, Boyd Gillespie M, Day TA. Young MR, et al. Cancer Immunol Immunother. 2007 Jul;56(7):1077-86. doi: 10.1007/s00262-006-0242-7. Epub 2006 Nov 10. Cancer Immunol Immunother. 2007. PMID: 17096152 Free PMC article.

3

Secretion of vascular endothelial growth factor by oral squamous cell carcinoma cells skews endothelial cells to suppress T-cell functions.

Mulligan JK, Day TA, Gillespie MB, Rosenzweig SA, Young MR. Mulligan JK, et al. Among authors: young mr. Hum Immunol. 2009 Jun;70(6):375-82. doi: 10.1016/j.humimm.2009.01.014. Epub 2009 Feb 12. Hum Immunol. 2009. PMID: 19480853 Free PMC article.

4

Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma.

Walsh JE, Clark AM, Day TA, Gillespie MB, Young MR. Walsh JE, et al. Among authors: young mr. Hum Immunol. 2010 Jul;71(7):659-65. doi: 10.1016/j.humimm.2010.04.008. Epub 2010 May 16. Hum Immunol. 2010. PMID: 20438786 Free PMC article. Clinical Trial.

5

Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.

Young MR, Lathers DM. Young MR, et al. Otolaryngol Head Neck Surg. 2005 Oct;133(4):611-8. doi: 10.1016/j.otohns.2005.05.658. Otolaryngol Head Neck Surg. 2005. PMID: 16213938

6

Incomplete Th2 skewing of cytokines in plasma of patients with squamous cell carcinoma of the head and neck.

Lathers DM, Achille NJ, Young MR. Lathers DM, et al. Among authors: young mr. Hum Immunol. 2003 Dec;64(12):1160-6. doi: 10.1016/j.humimm.2003.08.024. Hum Immunol. 2003. PMID: 14630398

7

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.

Lathers DM, Clark JI, Achille NJ, Young MR. Lathers DM, et al. Among authors: young mr. Cancer Immunol Immunother. 2004 May;53(5):422-30. doi: 10.1007/s00262-003-0459-7. Epub 2003 Nov 26. Cancer Immunol Immunother. 2004. PMID: 14648070 Free PMC article. Clinical Trial.

8

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.

Lathers DM, Young MR. Lathers DM, et al. Among authors: young mr. Cytokine. 2004 Mar 7;25(5):220-8. doi: 10.1016/j.cyto.2003.11.005. Cytokine. 2004. PMID: 15036248

9

Autocrine motility-stimulatory pathways of oral premalignant lesion cells.

Young MR, Neville BW, Chi AC, Lathers DM, Gillespie MB, Day TA. Young MR, et al. Clin Exp Metastasis. 2007;24(2):131-9. doi: 10.1007/s10585-007-9063-0. Epub 2007 Mar 17. Clin Exp Metastasis. 2007. PMID: 17370039

10

Tumors skew endothelial cells to disrupt NK cell, T-cell and macrophage functions.

Mulligan JK, Lathers DM, Young MR. Mulligan JK, et al. Among authors: young mr. Cancer Immunol Immunother. 2008 Jul;57(7):951-61. doi: 10.1007/s00262-007-0425-x. Cancer Immunol Immunother. 2008. PMID: 18058097 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

428 results

Search Page

Filters